Business Wire

Guangdong Film Europe Roadshow launched at 76th Venice International Film Festival

5.9.2019 05:58:00 EEST | Business Wire | Press release

Share

A Guangdong film Europe roadshow was launched during the 76th Venice International Film Festival on 3rd September, bringing some of its best productions in the recent years to European audience and seeking to promote cultural understanding and relations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190904006030/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Guangdong Film Europe Roadshow launched as Director of Guangdong Film Administration Bai Jie, Director of Film and Audiovisual at Italian Ministry of Cultural Heritage and Activities and Tourism Maria Troccoli, and other representatives of Guangdong film production institutions cut the ribbon at an event on the side of the 76th Venice International Film Festival on 3rd September. (Photo: Business Wire)

Guangdong, one of the most economically-developed provinces in China, is also traditionally strong in culture heritage and film production. This roadshow led by the Guangdong Film Administration kicked off in Venice, followed by Milan, Athens and Madrid.

“Mountains and oceans cannot part those who share the same vision,” said Bai Jie, the Director of Guangdong Film Administration, at the launching ceremony as part of the annual event “Focus on China” on the side of the Venice International Film Festival. “Both China and Italy boast a rich cultural heritage and represent the excellence of the Eastern and Western cultures.”

She believes that the art of film has long been playing a key role in fostering cross-cultural understanding, inspiring the minds, and enhancing the friendships between different countries. Therefore, this Europe roadshow is a chance for Guangdong Province to learn from the world and attract international investments, talents, technologies and resources to help Guangdong film industry go global.

On the Italian side, Maria Troccoli, Director of Film and Audiovisual, Italian Ministry of Cultural Heritage and Activities and Tourism; Roberto Stábile, Director of International Department, National Association of Cinematographic, Audiovisual and Multimedia Industries (ANICA); and the representatives of Italian film organizations attended the event. “We have established long-term exchange and cooperation relations with the Chinese film industry. We believe Guangdong film Europe roadshow will enhance our cultural exchange and bring more cooperation in the future,” said Stábile.

At the event, the Guangdong delegation presented the trailer of the films brought on the roadshow, including the first 4K Cantonese opera film “The Tale of the White Snake” by the Pearl River Film Group and a documentary about the changes to China produced by Shenzhen Media Group. In addition, an agreement was signed for a Chinese-Italian co-production film project titled “Survivor” as a latest achievement in the bilateral cooperation in the film industry.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Wei Wang
wangwei@xinhuaeurope.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Azafaros Announces Publication of Phase 2 RAINBOW Study Data for Nizubaglustat in Molecular Genetics and Metabolism Journal5.6.2026 08:00:00 EEST | Press release

Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced the publication of clinical data from its Phase 2 (RAINBOW) study in the peer reviewed journal, Molecular Genetics & Metabolism. The published manuscript reports efficacy, safety, pharmacokinetic and pharmacodynamic data which evaluated nizubaglustat in patients with genetically confirmed GM2 gangliosidosis and NPC. As previously stated in the topline results announcement in July 2024, the RAINBOW study met its primary objective of demonstrating that nizubaglustat was safe and well tolerated. The study also showed encouraging signs of clinical efficacy, reducing disease progression and seizure burden in patients treated with nizubaglustat. “The publication of the RAINBOW data in a peer-reviewed journal represents an important milestone for Azafaros and for the broader lysosomal disease community,” said Stefano Portolano,

K-Startup Grand Challenge 2026: Korea's Full-Cycle Launchpad for Global Startups5.6.2026 04:00:00 EEST | Press release

South Korea’s Ministry of SMEs and Startups (MSS) has opened applications for the K-Startup Grand Challenge (KSGC), the country’s premier government-backed acceleration program for international startups targeting Korea and Asia. Since 2016, KSGC has attracted 21,537 applicants from more than 100 countries, among the world's most recognized inbound programs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604794426/en/ South Korea’s Ministry of SMEs and Startups (MSS) has opened applications for K-Startup Grand Challenge 2026, a government-backed global startup acceleration program providing end-to-end support for international startups (Image: KSGC) A Full-Cycle Acceleration Journey Unlike conventional programs that focus on a single moment of market entry, KSGC 2026 guides startups from market entry to scale up in Korea - offered in a hybrid format - online or in person - with Demo Day held in Korea. The program runs Jul

Empire State Building Observation Deck Celebrates Soccer with World’s Most Iconic Soccer Jersey Exhibit, Custom ESB Jerseys, Player Visits, Lightings, and More5.6.2026 00:46:00 EEST | Press release

The Empire State Building Observation Deck (ESB) – the #1 Attraction in the United States – today announced further 2026 programming for soccer fans in New York City with the world’s most iconic jersey collection from the Classic Football Shirts (CFS) vault, a limited-edition ESB x CFS jersey, official merch giveaways, and special lightings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604370013/en/ Empire State Building Observation Deck Celebrates Soccer with World’s Most Iconic Soccer Jersey Exhibit, Custom ESB Jerseys, Player Visits, Lightings, and More “As the world descends upon New York City for this anticipated global soccer event, fans can visit the Empire State Building Observation Deck for Manhattan’s best skyline views and a one-of-a-kind soccer exhibit,” said Dan Rogoski, observatory general manager. “International and American soccer fans can extend the celebration off the pitch at the #1 Attraction in the

Vycellix to Provide Universal Cell Cancer Therapy Progress Reports at Upcoming Investor & Partnering Meetings4.6.2026 21:15:00 EEST | Press release

Vycellix, Inc., a biotechnology company developing next-generation allogeneic natural killer (NK) cell-based therapies designed to overcome the risk of immune rejection and redefine functional persistence with durability, today announced the Company will attend a series of upcoming investor and partnering meetings to share progress reports on the Company’s universal cell therapy platforms and product candidates targeting multiple myeloma, acute myeloid leukemia and urothelial cancers. Vycellix is attending: June 8-9: U.S. Department of Commerce Certified Trade Mission to Norway in Oslo June 11-14: European Hematology Association (EHA) 2026 Congress in Stockholm June 22-25: BIO International Convention in San Diego (Florida Pavilion, Booth# 1319) To request a meeting with Vycellix at any of these events, please contact Doug Calder at dcalder@vycellix.com. Vycellix recently announced the successful completion of pre-clinical development for its universal cell engineering platform (VY-UC)

Sodali & Co Appoints Fabio Bianconi as Head of Italy4.6.2026 20:15:00 EEST | Press release

Sodali & Co, the leading global capital markets-centric stakeholder advisory firm, today announced the appointment of Fabio Bianconi as Head of Italy, effective immediately. Fabio succeeds Andrea Di Segni, who will transition into a new role as Senior Relationship Advisor, where he will continue to support key client relationships and strategic initiatives across the firm. Fabio brings deep experience, strong client relationships, and a track record advising on complex mandates in the Italian market. He will lead Sodali’s continued growth and development in Italy, building on the firm’s established position in the region. Aneliya Crawford, Chief Partnerships Officer & Global Head of Shareholder Advisory of Sodali & Co, said: “Andrea has played a central role in the evolution of Sodali over more than two decades, helping establish the firm as a trusted global advisor in corporate governance and shareholder engagement. He built our Italian business into a leader in the market, as reflect

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye